摘要
目的:克隆人肿瘤坏死因子配体超家族(tumor necrosis factor superfamily,TNFSF)成员4-1BBL基因,构建其真核表达载体,并检测4-1BBL基因在Tca8113中的表达。方法:从淋巴细胞中提取RNA,用RT-PCR方法将4-1BBL的编码序列cDNA扩增。然后将该基因的编码序列插入真核荧光蛋白载体pEGFP-C1质粒中,构建成最终的表达载体pEGFP-Cl-4-1BBL。运用脂质体方法将pEGFP-Cl-4-1BBL转染Tca8113细胞,转染24h后,荧光显微镜下观察绿色荧光蛋白的表达,RT-PCR和免疫印迹检测4-1BBL在该细胞中的表达。经G418筛选后,用有限稀释法建立稳定高表达的带有4-1BBL基因的Tca8113细胞系。结果:从淋巴细胞中提取的RNA经RT-PCR扩增出目的基因4-1BBL,其全长大小为768bp。测序鉴定该序列与GenBank中的序列相同。转染pEGFP-Cl-4-1BBL载体的靶细胞Tca8113中,荧光显微镜下可见其表达绿色荧光蛋白,RT-PCR方法检测到目的基因4-1BBL的7686p大小的cDNA扩增产物。裂解的4-1BBL/Tca8113基因转染细胞膜蛋白中相对分子质量约27.5Kd的特异性条带。结论:转染4- 1BBL基因细胞株的建立,为该基因功能的后续研究和单克隆抗体的研制奠定了基础。
PURPOSE: To clone human 4-1BBL cDNA,which is a member of the tumor necrosis factor (TNF) ligand superfamily,construct an eukaryotic expression vector,pEGFP-C1-4-1BBL, and detect the expression of 4-1BB ligand(4- 1BBL) in Tca8113 cells. METHODS: Total RNA was isolated from PBMC lymph-cell, 4-1BBL cDNA was amplified by RT-PCR, PCR products of 4-1BBL were inserted into pEGFP-C1 to form the expression vector of pEGFP-C1-4-1BBL. Twenty-four hours after transfection of PEGFP-C1-4-1BBL into Tca8113 cell line by lipofectamine 2000, the expressions of GFP protein and 4-1BBL were detected by fluorescence microscopy, RT-PCR and Western blot, respectively. Transfected cells were selected in medium containing G418 (400μg/ml) and termed as Tca8113/4-1BBL, using definite dilution method, the cell line of Tca8113/4-1BBL was constructed. RESULTS: The sequence of 4-1BBL,768 bp,was confirmed by sequencing which was identical to be the human 4-1BBL mRNA in GenBank. The recombined expression vector PEGFP-C1-4-1BBL was determined by restriction enzyme digestion and PCR assay.Green fluorescence protein was expressed in Tca8113 cells that transferred by PEGFP-C1-4-1BBL. A 271 bp fragment of RT-PCR product was detected using the 4-1BBL specific primers. Western blot showed a belt about 27.5 kD protein. CONCLUSION: Construction of human 4-1BBL transfectant cell line has a great value for further study of 4-1BBL, which provides preparation of monoclone antibody of 4-1BBL. Supported by National Natural Science Foundation of China (Grant No.30672335), Guangdong Natural Science Foundation (Grant No.06027977) and Foundation of Shenzhen Bureau of Science, Technology and Information (Grant No. 200601008).
出处
《中国口腔颌面外科杂志》
CAS
2008年第3期188-193,共6页
China Journal of Oral and Maxillofacial Surgery
基金
国家自然科学基金(30672335)
广东省自然科学基金(06027977)
深圳市科技局重点基金(200601008)~~